A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where communities with numerous of members share comparison images, injection guides and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for transactions.
Understanding Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Professionals Express Worries
However, physicians and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could result in users administering substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.
Platform Reaction and Content Elimination
According to TikTok, the platform has taken down violative content and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of users, populated with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.
After moments of entering one community, a vendor posted WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience.
Product Details and Costs
Within these communities, posts display dark colored packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering substances they cannot confirm. Although the research behind this drug is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly serious medical dangers”.
